Apply Emerging Biomarkers to Improve Neurodegenerative Disease Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how biomarker strategies can support earlier detection, patient selection and treatment-response assessment in neurodegenerative disease research. The featured speakers will discuss biological and imaging biomarkers, digital health technologies and wearable devices, along with their use in clinical trial design and disease monitoring. Attendees will also explore practical considerations and emerging trends shaping biomarker-driven CNS drug development.

TORONTO, Oct. 27, 2026 /PRNewswire/ -- For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker science, digital health technologies and precision medicine are creating new ways to capture objective measures of disease. As the prevalence of neurodegenerative conditions continues to grow, there is an increasing need for innovative tools to detect disease, strengthen clinical trial design and support the development of new therapies. This webinar explores how emerging biomarker strategies can help address these challenges across clinical research and therapeutic development.

Biological and imaging biomarkers, together with digital and wearable technologies, are enabling researchers to detect disease earlier, characterize patient populations more accurately, track disease progression and assess treatment response with greater precision. These objective, actionable measures can help inform decision-making across the drug development process.

The featured panelists will examine how biological, digital and wearable markers are being applied across neurodegenerative disease research. Attendees will learn how these approaches can support more efficient clinical trials, strengthen patient selection, enable more personalized treatment strategies and contribute to the development of next-generation therapies.

The session will also examine real-world applications, practical implementation considerations and emerging trends influencing the future of CNS research. Attendees will gain insight into both the opportunities and challenges of incorporating innovative biomarker strategies into research programs and clinical development initiatives. As neurodegenerative disease research becomes increasingly precise, data-driven and patient-centered, biomarkers and digital technologies will play an important role in advancing new treatments and improving patient outcomes.

Register for this webinar to learn how biomarker strategies can advance neurodegenerative disease research and support more precise, data-driven clinical trials.

Join Bob Dagher, Chief Medical Officer, Clinilabs; Nicklas Linz, CEO and Co-Founder, Ki:elements; and Chiara Capra, Co-Founder & CEO, LIFE Neurotech & CPO, Sense4Care, for the live webinar on Tuesday, November 10, 2026, at 12pm EST (6pm CET / EU-Central).

For more information, or to register for this event, visit Apply Emerging Biomarkers to Improve Neurodegenerative Disease Trials.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks